Thus, tumor cells derived from melanoma patients seem to harbor a specific glyco-code characterized by high levels of GalNAc and NeuAc residues compared to their healthy counterpart, with variations in the expression of Man, Fuc and Gal motifs depending on their tissue localization. This evidence concerns the gene GAL and melanoma.